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Abstract: 
Childhood trauma has been linked to the development of later psychopathology, 
including obsessive-compulsive disorder (OCD). Although evidence exists to 
suggest that genetic and environmental factors are involved in the aetiology of 
OCD, little attention has been paid to the interactions that exist between genes 
and environment. The aim of this study was to investigate gene-by-
environment interactions between childhood trauma and the BDNF Val66Met 
variant in patients with OCD. 
 
Childhood trauma was assessed in 134 OCD patients and 188 controls using the 
Childhood Trauma Questionnaire (CTQ). Linear regression models were used 
for statistical analyses. Geneeenvironment interactions were estimated by 
including a combined genotype and CTQ score in the models as interaction 
terms. All analyses were adjusted for age, gender, CTQ minimisation-denial 
score and home language by including them in the logistic regression models as 
covariates. 
 
Childhood trauma, speciﬁcally emotional abuse and neglect, increased the odds 
of having OCD signiﬁcantly (p < 0.001). Although no signiﬁcant association was 
observed between BDNF Val66Met and the development of OCD, interaction 
analysis indicated that the BDNF Met-allele interacted with childhood emotional 
abuse to increase the risk of OCD signiﬁcantly in a dose-dependent manner (p < 
0.024). To our knowledge, this is one of the ﬁrst studies to investigate 
geneeenvironment interactions in OCD, and the ﬁndings indicate the importance 
of collating genetic and environmental variables in future studies. 
 
1. Introduction 
Obsessive-compulsive disorder (OCD) is a chronic and disabling psychiatric disorder with 
a lifetime prevalence of approximately 2% (Angst et al., 2004; Ruscio et al., 2010). A 
number of twin (van Grootheest et al., 2005) and family (Black et al., 1992; Do Rosario- 
Campos et al., 2005; Hanna et al., 2005; van Grootheest et al., 2005; Nicolini et al., 
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2009; Pauls, 2010) studies indicate that genetic factors contribute to its aetiology. The 
environment has also been found to play a role in the development of the disorder e 
twin studies indicate that approximately 50% of individual variation in OCD is due to non-
genetic, environmental factors (Samuels, 2009).  
 
A number of environmental risk factors have been identiﬁed for OCD, including stressful 
and traumatic life events (McKeon et al.,1984; Gothelf et al., 2004). However, childhood 
trauma and its association with the development of OCD has, to date, not been widely 
studied. Mathews et al. (2008) investigated the association between childhood trauma and 
obsessive-compulsive (OC) symptoms in a community sample and found that, although 
emotional abuse and physical neglect were associated with the occurrence of OC 
symptoms, this was dependent on the co-occurrence of anxiety symptoms. However, the 
authors did observe a direct association between emotional abuse and high levels of OC 
symptoms (‘probable’ OCD). Briggs and Price (2009) observed an association between 
adverse childhood experience and OC symptoms, but only in the presence of anxiety and 
depression. In one of the few studies to investigate the association between childhood 
trauma and clinical OCD thus far, Lochner et al. (2002) observed a signiﬁcant association 
between childhood emotional neglect and OCD in females. However, not all individuals 
who experience childhood adversity will necessarily develop psychopathology or OCD 
specifically; arguably a pre-existing vulnerability is required to interact with the adverse life 
event(s) to increase risk. 
 
Gene-by-environment (G x E) interaction analyses investigate the role that environmental 
factors play in the development of a disorder, and how genetic constitution possibly 
modiﬁes this association. A number of studies have indicated that brain-derived 
neurotrophic factor (BDNF) plays a role in modulating the outcome of childhood trauma 
in terms of psychopathology (Perroud et al., 2008; Aguilera et al., 2009; Gatt et al., 2009; 
Pregelj et al., 2011). BDNF is a key neurotrophin that is widely expressed in the mammalian 
brain, where it plays a crucial role in neurodevelopment, morphology and differentiation, 
and synaptic plasticity (Hoglinger et al., 1998; Huang and Reichardt, 2001; Lu, 2003; 
Duman and Monteggia, 2006). BDNF has also been hypothesised to play a role in the 
development of OCD (Stein et al., 2008). The gene encoding BDNF contains a single 
nucleotide polymorphism (SNP) resulting in a valine-to-methionine substitution at amino 
acid 66 (Val66Met, rs6265) in the 50 pro-BDNF domain. The Met-allele has been found to 
affect the intracellular trafﬁcking of the pro-BDNF polypeptide, thereby inhibiting the 
secretion of BDNF from activated neurons (Egan et al., 2003). BDNF Val66Met has been 
widely investigated in OCD, but the results have been largely inconsistent. Hall et al. 
(2003) observed an association between the Val-allele and childhood-onset OCD, although 
this result was not replicated in a later study (Mossner et al., 2005). Our group observed an 
association between the Met-allele and OCD in male patients with early-onset OCD 
(Hemmings et al., 2008). However, in the same study, the Val/Val genotype was found to be 
associated with increased severity of OCD in females. In an extension of our study, Katerberg 
et al. (2009) observed an association between female Met-allele carriers and less severe 
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OCD. However, Dickel et al. (2007), Wendland et al. (2007), Alonso et al. (2008) and 
Tukel et al. (2012) found no association between BDNF Val66Met and OCD. 
 
Numerous studies have implicated BDNF Val66Met in moderating the effect of stressful life 
events and the subsequent risk for psychopathology. For example, it has been shown that Met-
allele carriers are more vulnerable to stress (Casey et al., 2009) and to the development of 
depression (Carver et al., 2011), after experiencing early life adversity. To our knowledge, 
there are no studies investigating whether BDNF Val66Met moderates the effect of stressful 
life events and risk for OCD. The aim of the present study was thus to investigate the role that 
the BDNF Val66Met variant may play in moderating the causal effect of early life stress on the 
susceptibility to OCD. 
 
2.  Methods 
2.1. Recruitment, clinical assessment and self-report measures 
Unrelated South African Caucasian individuals with a primary diagnosis of OCD (n = 134) 
were recruited through physician referral, media advertisements, the Mental Health 
Information Centre of Southern Africa (MHIC) and the OCD Association of South Africa 
(OCDSA). Controls (n = 188) comprised randomly selected Caucasian blood donors who were 
given a brief screening test and were self-declared psychologically healthy (i.e. not 
diagnosed with any psychiatric disorders). For the purposes of this study, South African 
Caucasians were classiﬁed as those participants who were white and had self-reported home 
languages of English and/or Afrikaans. 
 
Speciﬁc demographic data, including age at interview and gender were obtained from 
all participants. Patients were assessed for a primary diagnosis of DSM-IV OCD using the 
Structured Clinical Interview for Axis I Disorders e Patient Version (SCID-I/P) (First et 
al., 1998). The Structured Clinical Interview for Obsessive-Compulsive Spectrum 
Disorders (SCID-OCSD) (Du Toit et al., 2001) was administered by a trained mental 
health professional (i.e. a clinical psychologist, psychiatrist or psychiatric nurse) and 
was used to assess comorbid OCD-related conditions not covered in the SCID-I/P. OCD 
patients with a signiﬁcant history of neurological disease, schizophrenia, schizo-affective 
disorder, other psychotic conditions or a history of substance dependence, as 
determined from the interviews or previous medical records, were excluded from the 
study. Patients at baseline (not receiving any form of treatment for OCD) as well as 
patients on treatment for OCD were included in the study. 
 
The Yale-Brown Obsessive-Compulsive Severity Scale (YBOCS) was used to assess of the 
severity of obsessive-compulsive symptoms (Goodman et al., 1989). The Childhood Trauma 
Questionnaire (short form) (CTQ-SF) (Bernstein and Fink, 1998) was used to assess ﬁve 
types of negative childhood experiences, namely physical abuse, physical neglect, 
emotional abuse, emotional neglect and sexual abuse, in both the OCD and control groups. 
Each item was rated from 1 (never) to 5 (very often). Total scores ranged from 5 to 25 for 
each type of trauma. The minimisation/denial scale of the CTQ provides an indication of 
potential underreporting of childhood maltreatment, and thus false-negatives. The scale 
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comprises three items, and scoring was dichotomised (“very often true” ¼ 1; all other 
responses ¼ 0) and summed. A total of one or above indicates possible underreporting of 
maltreatment (Bernstein and Fink, 1998), while the highest score of three represents 
extreme misrepresentation or denial of childhood maltreatment. 
 
The protocol was approved by the Health Research Ethics Committee at Stellenbosch 
University, and all participants provided written, informed consent after being presented 
with a complete description of the study. 
 
2.2 DNA extraction, ampliﬁcation and genotyping 
Peripheral blood was drawn from all participants and genomic DNA was subsequently 
extracted from each blood sample using the standard phenol/chloroform method. The 
BDNF Val66Met polymorphism (rs6265) was genotyped as previously described 
(Hemmings et al., 2008). 
 
2.3 Statistical analyses 
Fisher’s exact test was used to compare gender and home language and a t-test was used 
to compare age at assessment between the two diagnostic groups (OCD and control). Only 
home language differed signiﬁcantly between the diagnostic groups. However, as all the 
aforementioned variables are possible confounders, all subsequent analyses were 
adjusted for age, gender and home language (as a proxy for possible population 
structure). It is essential to correct for population structure, given that spurious 
association may result if the genetic background of the sub-populations comprising the 
sample under investigation differ (Astle and Balding, 2009). 
 
Dichotomous (e.g. susceptibility to OCD and gender) and categorised variables (home 
language) were summarised as counts and percentages (%). Dichotomous outcomes (i.e.  
the dependent variables) were analysed using logistic regression models, to facilitate 
adjustment for confounders (i.e. the independent variables). Numerical dependent 
variables (i.e. age at assessment, age at onset of OCD, CTQ scores) were analysed using 
linear models, to enable adjustment for confounders (i.e. the independent variables), and 
summarised as medians (interquartile ranges [IQRs]), since some had skewed 
distributions. 
 
Genetic association with OCD (the diagnosis being a dichotomous dependent variable) 
was assessed in two ways: by coding genotypes as categories (with 2 degrees of freedom) 
or minor additive allele counts (1 degree of freedom) (where it is assumed that the 
combined effect of each of the alleles is equal to the sum of the individual effects of each 
allele). For testing the interaction between CTQ score and a genetic variable on OCD, a 
statistical additive allelic-by-CTQ interaction term (independent numerical variable) 
(together with main effects [independent variables]) was included in the models (where 
‘additive allele’ refers to the number of minor alleles). 
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A p < 0.05 was considered signiﬁcant. The freely available programming environment, R, 
was used for all statistics. The R package genetics  (Warnes et al., 2011) was used to estimate 
HardyeWeinberg equilibrium probabilities, and genotype and allele frequencies. 
 
3 Results 
3.1 Demographic  variables 
In total, 134 OCD patients (54 [40%] male; 80 [60%] female) and 188 control participants 
(80 [43%] male; 108 [57%] female) were included. Gender distributions were similar in the 
diagnostic groups (p = 0.731). Age at assessment was recorded for 187 (99%) OCD patients 
and all the controls, with medians of 34 years (range: 12-71 years) and 34 years (range: 17-
72 years) for the OCD and control groups, respectively (p = 0.288). The home language 
distribution differed signiﬁcantly between OCD and control groups (p < 0.001). The 
majority of the sample was Afrikaans-speaking in both the OCD (52%) and control (65%) 
groups, with English-speaking individuals comprising 44% and 22% of the OCD and control 
groups, respectively. The remainder of the sample comprised those who were both English 
and Afrikaans-speaking. All subsequent analyses were adjusted for gender, age and home 
language. 
 
3.2.   Clinical variables 
Data pertaining to age at onset of OCD was available for 127 (95%) (51 [94%] male, and 76 
[95%] female) patients. The median age at onset of OCD was 13 years (interquartile range 
[IQR] = 8.5e 22 years), and the median YBOCS score was 21 (IQR = 16e24). The most 
prevalent comorbid disorder was major depressive disorder (MDD), which was diagnosed 
in 63% (84/134) of the OCD patients. Table 1 provides a summary of the frequency of 
self-reported childhood trauma in the OCD and control groups for each of the CTQ  
subscales.  Median  total  and  subscale  CTQ  scores  were compared between OCD and 
control groups, and all models were adjusted for age, gender, language and CTQ 
minimisation/denial score (Table 2). Because more than half of the OCD patients presented 
with comorbid MDD, it was necessary to determine whether any signiﬁcant associations 
observed could be attributed to  the presence of OCD alone, or to the co-occurrence of the 
two disorders. The p-values in the last two columns of Table 2 compare the CTQ scores 
between: i) OCD and control groups and ii) OCD patients with comorbid MDD and those 
without MDD. 
 
Emotional  neglect  was  the  most  common  form  of  childhood trauma in both the OCD 
and control groups (Table 1). A higher total CTQ score was found to be signiﬁcantly 
associated with OCD (p = 0.005) (Table 2). Speciﬁcally, OCD patients were found to 
possess signiﬁcantly higher levels of emotional abuse and neglect compared to control 
participants (p < 0.001 for both comparisons). For each unit increase in emotional abuse 
or neglect CTQ score, the odds ratio of having OCD (versus not having OCD) was 1.14 (95% 
CI: 1.07e1.22 and 95% CI: 1.08e1.23 for a unit increase in emotional abuse and emotional 
neglect score, respectively). When emotional abuse and emotional neglect scores were 
compared between those individuals with comorbid MDD and those without, no signiﬁcant 
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differences were observed (p = 0.224 and p = 0.093 for emotional abuse and emotional 
neglect, respectively) (Table 2). 
 
Within the OCD group, male OCD patients were found to report signiﬁcantly more 
emotional neglect (p =  0.01), with the median CTQ score for emotional neglect in males 
being 13 [IQR: 8-17] compared to 9 [IQR: 6-13] for females. Total CTQ score was not 
associated with age at onset (p = 0.823); however, individuals with  increased  emotional  
abuse  scores  exhibited  signiﬁcantly increased YBOCS severity scores  (p  =  0.031;  
increase  in YBOCS = 0.31 [95% CI: 0.03-0.59] for a unit increase in emotional abuse  
score).  In  addition,  physical  neglect  was  found  to  be nominally associated with 
comorbid MDD (p =  0.047; OR of MDD for a unit increase in physical neglect score = 1.27 
[95% CI: 1.03-1.67]) (Table 2). 
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3.3.  Genetic variables 
DNA was available for 121 (90%) OCD patients and 187 (99%) controls. The BDNF 
Val66Met SNP was in HardyeWeinberg equilibrium (p = 0.601 in the control group). 
Table 3 indicates the genotype counts and percentages for BDNF Val66Met in the OCD 
and control groups. 
 
No statistically signiﬁcant associations were observed when genotype and allele 
distributions of BDNF Val66Met were compared between  the  OCD  and  control  groups  
(p  =  0.987  [genotype], p =  0.914 [allele]) (Table 3). 
 
3.4. G x E interactions 
The p-values for the interaction between BDNF Val66Met and reported childhood trauma 
on OCD susceptibility are provided in Table 4. All values are adjusted for age, gender, 
language and CTQ minimisation/denial score. 
 
A box plot indicating the distribution of CTQ scores per BDNF Val66Met genotype, in 
OCD patients and controls is indicated in Fig. 1. BDNF Val66Met was found to interact 
with emotional abuse on the risk of OCD, in a dose-dependent manner. The predicted 
increase in the odds of having OCD, for one unit increase in emotional abuse CTQ 
score, is 35% for heterozygous individuals and 61% for individuals homozygous for the 
Met-allele. This signiﬁcant interaction is illustrated in Fig. 2. 
 
Box plots representing the distribution of age at onset and YBOCS score per BDNF 
Val66Met genotype are provided in Figs. 3 and 4, respectively. No signiﬁcant associations 
were observed between BDNF Val66Met and age at onset (p =  0.711) or YBOCS score (p =  
0.832). When the effect of the interaction between BDNF Val66Met and CTQ score on age 
at onset of OCD was investigated, we observed no signiﬁcant association (p = 0.316 for 
total CTQ score). Likewise, no signiﬁcant association was observed when the interaction 
between BDNF Val66Met and CTQ score on YBOCS severity score was analysed (p =  0.900 
for total CTQ score). 
 
4.  Discussion 
To our knowledge, this study is the ﬁrst to investigate the interaction between 
childhood trauma and OCD, and the manner in which this relationship is modiﬁed by 
BDNF Val66Met. To this end, OCD patients reported signiﬁcantly more childhood 
trauma in the form of emotional neglect and emotional abuse compared to controls. 
These results are in line with previous ﬁndings from our group, where childhood 
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emotional neglect was found to be signiﬁcantly increased in female OCD patients 
compared to controls (Lochner et al., 2002). The present study utilised a subset of the 
patients and controls investigated in the earlier study; however, the sample size in the 
present study was signiﬁcantly larger, and included male OCD and control participants, 
complementing and expanding on the previous study. 
 
The estimated risk of OCD in individuals who had experienced childhood emotional abuse 
was associated with the BDNF Met-allele in a dose-dependent manner, with individuals 
homozygous for the BDNF Met-allele (carrying two Met-alleles) possessing almost 
double the risk of having OCD compared to Val66Met heterozygotes (carrying  only  one 
Met-allele). The BDNF Val66Met polymorphism is functional, with the Met-allele 
resulting in reduced activity-dependent secretion of BDNF (Egan et al., 2003). Stress has 
been found to compound the effects that the BDNF Met-allele has on BDNF levels, 
resulting in increased anxiety and depression (Gatt et al., 2009; Elzinga et al., 2011). 
Indeed, Met-allele carriers have been found to be more sensitive to childhood abuse 
than Val-carriers, which could result in later psychopathology. This may be due to 
reduced neural plasticity caused by the altered release of BDNF during development 
(Gatt et al., 2009). Although childhood emotional abuse was found to increase the 
severity of OCD, no interactive effect between childhood trauma and BDNF Val66Met 
on severity of OCD was observed in the present study, indicating that other factors, 
environmental and/or genetic, may be acting in concert with childhood trauma to increase 
severity of the disorder. 
 
The ﬁndings in the present study underscore the importance of considering G x E 
interactions in OCD association studies, and may, at least partially, explain some of the 
inconsistencies observed in previous studies investigating the role that BDNF may play in 
the development of OCD. Previous studies have implicated both the BDNF Val- (Hall et 
al., 2003) and Met-alleles in the development of OCD (Hemmings et al., 2008; Katerberg et 
al., 2009). Our group has previously found that the Met-allele represented a risk allele for the 
development of OCD in males, while females homozygous for the Val-allele exhibited 
more severe OCD symptoms (Hemmings et al., 2008; Katerberg et al., 2009). 
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In the present study, we found that the Met-allele is particularly associated with OCD in 
the presence of early adversity; thus it could be argued that it is not that BDNF has 
different associations based on gender, but rather that the inconsistent results are due 
to variation in early adversity. 
 
Due to the high degree of comorbid MDD in the OCD group, we investigated the 
probability that childhood trauma was linked to the development of comorbid MDD, 
and was not unique to the development of OCD. No signiﬁcant differences in CTQ 
scores between OCD individuals with comorbid MDD and those without were noted, 
making it difﬁcult to decipher whether childhood trauma was signiﬁcantly 
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associated with the development of OCD or the co-occurrence of the two disorders. 
This represents a limitation of the present study, and should be rectiﬁed in future 
studies comprising larger study groups. 
 
Other limitations in the present study deserve mention. First, the present study 
included only one type of environmental risk factor (childhood adversity) in the 
analyses. There are, however, numerous environmental factors that have been 
identiﬁed as increasing the risk for OCD that could be included in future 
investigations. In addition, more recent life events may perhaps have had more 
inﬂuence on the development of OCD than more distal events, as has been found in 
depression (Middeldorp et al., 2010). One should also account for the possibility that 
negative outcomes often associated with childhood adversity may be modiﬁed by 
subsequent environmental factors, such as available positive social support and optimal 
caregiving experiences (Barbazanges et al., 1996; Kaufman et al., 2000; Huot et al., 
2004). Positive environmental factors that could ameliorate the development of 
psychopathology should thus be incorporated into future G x E studies. 
 
Second, the CTQ, although a reliable and validated means of trauma assessment 
(Bernstein and Fink, 1998), may be vulnerable to a number of biases, including recall 
bias, by virtue of its self-assessment, retrospective qualities. Third, a crucial 
assumption in all G x E studies is that genetics and environmental factors are 
independent, because the presence of geneeenvironment correlation (rGEs) confound 
the identiﬁcation and subsequent interpretation of G x E interactions (Mofﬁtt et al., 
2005; Jaffee and Price, 2007). Geneeenvironment correlation was not  corrected  for  
in the present study; thus the signiﬁcant interaction effects should be regarded as 
preliminary and requiring replication. 
 
Finally, it is important to note that controls used in the present study were from a 
cohort of “convenience controls” i.e. they were randomly selected Caucasian blood 
donors who, although they were given a brief psychiatric screening test, did not 
undergo a structured interview. We can therefore not rule out the possibility that this 
screening procedure may have overlooked  individuals with sub-threshold or mild OCD. 
 
Despite the limitations, the present study sheds light on the G x E interaction in the 
development of OCD, and as such, implicates interaction between BDNF Val66Met 
and childhood adversity in the development  of  the  disorder.  Studies  incorporating  
interactions between genes and the environment may improve our understanding of 
inconsistent results that are obtained frequently in genetic association studies, and 
may improve replicability of future studies. 
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